Cipla Limited has unveiled a strategic collaboration with Kemwell Biopharma Private Limited and Manipal Education & Medical Group, aiming to establish a joint venture in the United States. The venture is dedicated to the development and commercialization of innovative cell therapy products, addressing significant unmet medical needs across the United States, Japan, and EU regions.
As of 1:29 pm, the shares demonstrated positive market dynamics, trading 1.48% higher at ₹1,290.60. The strategic collaboration marks a significant move for the company, positioning itself to contribute to the advancement of cell therapy solutions and addressing critical medical needs in key global markets.